-
17 Jul 2026
GSK provides an update on CALM-1 and CALM-2 phase III trials for camlipixant in refractory chronic cough (RCC)
by GSK News Feed
- Views 4
- More stats
-
21 Jul 2026
ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026
by GSK News Feed
- Views 4
- More stats
-
22 Jul 2026
Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
by GSK News Feed
- Views 4
- More stats
-
27 Jul 2026
ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV
by GSK News Feed
- Views 4
- More stats
-
28 Jul 2026
GSK delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 2026
by GSK News Feed
- Views 4
- More stats
-
28 Jul 2026
GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK
by GSK News Feed
- Views 4
- More stats
-
29 Jul 2026
Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026
by GSK News Feed
- Views 4
- More stats
-
24 Aug 2026
Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B
by GSK News Feed
- Views 4
- More stats
-
24 Aug 2026
Jemperli (dostarlimab) accepted for priority review by the US FDA for dMMR/MSI-H locally advanced rectal cancer
by GSK News Feed
- Views 4
- More stats
-
10 Sep 2026
GSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Japan
by GSK News Feed
- Views 4
- More stats
Latest News in Life Sciences
Read the latest news, announcements and press releases from life sciences and related disciplines, including news from biotechnology and pharmaceutical research and development. When you join Life Science Network, you can follow your favorite sources to get notified when content matching your interests is published.
You can post a news article here
Join Life Science Network
Join LSN to acces all jobs and fully benefit from the platform and its features.
News module
Are you interested in posting articles on Life Science Network?
Please continue reading here.
For more information about Life Science Network,
contact us at [email protected].
Advertisement